Skip to content
Clinical Trials – home

Pratia Wroclaw Sp. z o.o.

Research site

Poland Ul. Podwale 83/10.2, 50-414 Wroclaw, Poland

  • 1 trial recruiting
  • Lennox-Gastaut syndrome · Myasthenia gravis · Partial seizures
  • Adults and children

About Specializations

Pratia Wroclaw Sp. z o.o. in Wroclaw, Poland specialises in clinical trials of conditions such as Lennox-Gastaut syndrome, Myasthenia gravis, Partial seizures, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Diseases Research

At Pratia Wroclaw Sp. z o.o., investigators focus on innovative approaches for seizure disorders within the nervous system.

  • Lennox‑Gastaut syndrome (LGS)
  • Refractory focal onset epilepsy
  • Adjunctive therapy evaluation
  • Safety and tolerability studies

Current trials assess the efficacy of new anti‑seizure compounds, aiming to reduce drop seizures and achieve meaningful seizure reduction for both pediatric and adult patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Podwale 83/10.250-414 WroclawPoland
Recruiting now
1 trial
Conditions studied
3

More sites in WroclawPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Study on Carisbamate for Treating Seizures in Children and Adults with Lennox-Gastaut Syndrome

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Carisbamate
  • Sponsor:Sk Life Science Inc.

Partial seizures

Not yet recruiting

Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BHV-7000
  • Sponsor:Biohaven Therapeutics Ltd.

Myasthenia gravis

Not yet recruiting

Efficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:DNTH103
  • Sponsor:Dianthus Therapeutics Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.